SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CalAsia Pharmaceuticals, Inc. , a Structure-Based Drug-Discovery Company; Seeks Corporate Partners to Complete the Pre-Clinical Development of Its Proprietary HSP90 Inhibitor Series